Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryota Hashimoto

Showing results (121-130 of 466) with videos related to

Pageof 47
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 16, 2011
[Translational research for mental disorder -schizophrenia]Ryota Hashimoto, Yuka Yasuda, Kazutaka Ohi, et al.
Psychiatry and Clinical Neurosciences|November 26, 2010
Apolipoprotein E and central nervous system disorders: reviews of clinical findingsMasatoshi Takeda, Rocío Martínez, Takashi Kudo, et al.
Neuromolecular Medicine|July 24, 2014
Aberrant DNA methylation of blood in schizophrenia by adjusting for estimated cellular proportionsMakoto Kinoshita, Shusuke Numata, Atsushi Tajima, et al.
Biochemical and Biophysical Research Communications|May 17, 2006
Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindinNatsuko Kumamoto, Shinsuke Matsuzaki, Kiyoshi Inoue, et al.
Neuropsychopharmacology Reports|February 12, 2025
Usefulness of the WAIS-IV Short Form for Measuring Cognitive Function in Patients With SchizophreniaSatsuki Ito, Chika Sumiyoshi, Junya Matsumoto, et al.
Schizophrenia Research. Cognition|July 2, 2026
A multilayered model of work outcome in patients with schizophrenia: Examination of the relationships among positive symptoms, cognition, and daily living skillsSatsuki Ito, Junya Matsumoto, Chika Sumiyoshi, et al.
Journal of Human Genetics|April 23, 2011
Dysbindin-1 and NRG-1 gene expression in immortalized lymphocytes from patients with schizophreniaHidenaga Yamamori, Ryota Hashimoto, Louise Verrall, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|April 19, 2003
[Neuroprotective actions of lithium]Ryota Hashimoto, Koichiro Fujimaki, Mi Ra Jeong, et al.
Psychiatry and Clinical Neurosciences|December 10, 2013
Relation between remission status and attention in patients with schizophreniaMotoyuki Fukumoto, Ryota Hashimoto, Kazutaka Ohi, et al.
Psychiatry and Clinical Neurosciences|March 2, 2022
Toward recovery in schizophrenia: Current concepts, findings, and future research directionsToshiaki Onitsuka, Yoji Hirano, Takanobu Nakazawa, et al.
Pageof 47

Showing results (121-130 of 466) with videos related to

Sort By:
Pageof 47
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 16, 2011
[Translational research for mental disorder -schizophrenia]Ryota Hashimoto, Yuka Yasuda, Kazutaka Ohi, et al.
Psychiatry and Clinical Neurosciences|November 26, 2010
Apolipoprotein E and central nervous system disorders: reviews of clinical findingsMasatoshi Takeda, Rocío Martínez, Takashi Kudo, et al.
Neuromolecular Medicine|July 24, 2014
Aberrant DNA methylation of blood in schizophrenia by adjusting for estimated cellular proportionsMakoto Kinoshita, Shusuke Numata, Atsushi Tajima, et al.
Biochemical and Biophysical Research Communications|May 17, 2006
Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindinNatsuko Kumamoto, Shinsuke Matsuzaki, Kiyoshi Inoue, et al.
Neuropsychopharmacology Reports|February 12, 2025
Usefulness of the WAIS-IV Short Form for Measuring Cognitive Function in Patients With SchizophreniaSatsuki Ito, Chika Sumiyoshi, Junya Matsumoto, et al.
Schizophrenia Research. Cognition|July 2, 2026
A multilayered model of work outcome in patients with schizophrenia: Examination of the relationships among positive symptoms, cognition, and daily living skillsSatsuki Ito, Junya Matsumoto, Chika Sumiyoshi, et al.
Journal of Human Genetics|April 23, 2011
Dysbindin-1 and NRG-1 gene expression in immortalized lymphocytes from patients with schizophreniaHidenaga Yamamori, Ryota Hashimoto, Louise Verrall, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|April 19, 2003
[Neuroprotective actions of lithium]Ryota Hashimoto, Koichiro Fujimaki, Mi Ra Jeong, et al.
Psychiatry and Clinical Neurosciences|December 10, 2013
Relation between remission status and attention in patients with schizophreniaMotoyuki Fukumoto, Ryota Hashimoto, Kazutaka Ohi, et al.
Psychiatry and Clinical Neurosciences|March 2, 2022
Toward recovery in schizophrenia: Current concepts, findings, and future research directionsToshiaki Onitsuka, Yoji Hirano, Takanobu Nakazawa, et al.
Pageof 47